The Methamphetamine Precursor Control Act (MPCA, 720 ILCS 648) is an Illinois state law that was signed into law on November 16, 2005, and took effect on January 15, 2006.[1] The MPCA is an act used to create significant barriers such as the requirement to present ID to purchase cold medication that contains pseudoephedrine (Sudafed, Tylenol Cold and Claritin D) which could be used to produce methamphetamine.[2] This is one of many state laws regulating the supply of pseudoephedrine that preceded the federal Combat Methamphetamine Epidemic Act of 2005.
The Act was introduced in the 94th Illinois General Assembly by senator James A. DeLeo as Senate Bill 273, on February 3, 2005.[3]
YouTube Encyclopedic
-
1/3Views:3 05320 917318
-
Stimulant Use Current Trends, Impact on the Brain and Body, and Implications for Treatment
-
Clandestine Lab Cleanup (Methamphetamine Lab)
-
Pseudoephedrine | Wikipedia audio article
Transcription
Methamphetamine Precursor Control Act - Amended
In 2008, the Illinois state legislature amended[specify] the MPCA creating a regional authority to establish a pilot program that targets individuals who are circumventing the law. As a result, the Southern Illinois counties of Williamson, Jackson, Union, Saline, Franklin, and Johnson, comprise the Illinois Meth Precursor Control Pilot Authority (IMPCPA).[4]
References
- ^ "720 ILCS 648/Methamphetamine Precursor Control Act". www.ilga.gov. Retrieved 2022-01-16.
- ^ Decker, John F.; Kopacz, Christopher (2012-07-05). Illinois Criminal Law Student Edition. LexisNexis. ISBN 978-0-327-17691-6.
- ^ "Illinois General Assembly - Bill Status for SB0273". Retrieved 2022-06-07.
- ^ "Meth continues to plague rural Illinois". Medill Reports Chicago. 2016-03-01. Retrieved 2022-01-16.
 | This Illinois-related article is a stub. You can help Wikipedia by expanding it. |
  | This article relating to law in the United States or its constituent jurisdictions is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 7 June 2022, at 23:28